{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:36:53Z","timestamp":1789051013873,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent studies have suggested a relationship between gut microbiota and non-alcoholic fatty liver disease (NAFLD)\/nonalcoholic steatohepatitis (NASH). However, the nature and direction of this potential causal relationship are still unclear. This study used two-sample Mendelian randomization (MR) to clarify the potential causal links.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Summary-level Genome-Wide Association Studies (GWAS) statistical data for gut microbiota and NAFLD\/NASH were obtained from MiBioGen and FinnGen respectively. The MR analyses were performed mainly using the inverse-variance weighted (IVW) method, with sensitivity analyses conducted to verify the robustness. Additionally, reverse MR analyses were performed to examine any potential reverse causal associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our analysis, primarily based on the IVW method, strongly supports the existence of causal relationships between four microbial taxa and NAFLD, and four taxa with NASH. Specifically, associations were observed between Enterobacteriales (\n                      <jats:italic>P<\/jats:italic>\n                      =0.04),\n                      <jats:italic>Enterobacteriaceae<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      =0.04),\n                      <jats:italic>Lachnospiraceae UCG-004<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      =0.02), and\n                      <jats:italic>Prevotella9<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      =0.04) and increased risk of NAFLD.\n                      <jats:italic>Dorea<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      =0.03) and\n                      <jats:italic>Veillonella<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      =0.04) could increase the risks of NASH while\n                      <jats:italic>Oscillospira<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      =0.04) and\n                      <jats:italic>Ruminococcaceae UCG-013<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      =0.005) could decrease them. We also identified that NAFLD was found to potentially cause an increased abundance in\n                      <jats:italic>Holdemania<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      =0.007) and\n                      <jats:italic>Ruminococcus2<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      =0.002). However, we found no evidence of reverse causation in the microbial taxa associations with NASH.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identified several specific gut microbiota that are causally related to NAFLD and NASH. Observations herein may provide promising theoretical groundwork for potential prevention and treatment strategies for NAFLD and its progression to NASH in future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2023.1294826","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T11:52:40Z","timestamp":1701517960000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Association between gut microbiota and NAFLD\/NASH: a bidirectional two-sample Mendelian randomization study"],"prefix":"10.3389","volume":"13","author":[{"given":"Qilong","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"B32","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/liv.14453","article-title":"Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"40","author":"Adams","year":"2020","journal-title":"Liver Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet. Epidemiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.14218\/jcth.2018.00008","article-title":"Fatty liver disease and gut microbiota: A comprehensive update","volume":"7","author":"Campo","year":"2019","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103592","article-title":"Kidney damage causally affects the brain cortical structure: A Mendelian randomization study","volume":"72","author":"Chen","year":"2021","journal-title":"EBioMedicine."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/srep34055","article-title":"Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrgastro.2011.133","article-title":"The intestinal microbiota and chronic disorders of the gut","volume":"8","author":"DuPont","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2223339","article-title":"Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis","volume":"15","author":"Gomez-Perez","year":"2023","journal-title":"Gut Microbes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"30","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00174-20","article-title":"The changing face of the family enterobacteriaceae (Order: \"Enterobacterales\"): new members, taxonomic issues, geographic expansion, and new diseases and disease syndromes","volume":"34","author":"Janda","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.dld.2023.07.014","article-title":"Association between the gut microbiota and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study","volume":"55","author":"Li","year":"2023","journal-title":"Dig Liver Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/nu15020360","article-title":"Causal effects of specific gut microbiota on chronic kidney diseases and renal function-A two-sample mendelian randomization study","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients."},{"key":"B25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","article-title":"Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Lipids Health Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hep.31523","article-title":"The commensal microbe veillonella as a marker for response to an FGF19 analog in NASH","volume":"73","author":"Loomba","year":"2021","journal-title":"Hepatology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/jrms.jrms_673_21","article-title":"Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis","volume":"27","author":"Mohammadi","year":"2022","journal-title":"J. Res. Med. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/nu12041096","article-title":"You are what you eat-the relationship between diet, microbiota, and metabolic disorders-A review","volume":"12","author":"Moszak","year":"2020","journal-title":"Nutrients."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002314","article-title":"Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study","volume":"14","author":"Noyce","year":"2017","journal-title":"PloS Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","article-title":"A universal gut-microbiome-derived signature predicts cirrhosis","volume":"32","author":"Oh","year":"2020","journal-title":"Cell Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/gepi.22207","article-title":"Implementing MR-PRESSO and GCTA-GSMR for pleiotropy assessment in Mendelian randomization studies from a practitioner's perspective","volume":"43","author":"Ong","year":"2019","journal-title":"Genet. Epidemiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/diagnostics13040614","article-title":"The link between NAFLD and metabolic syndrome","volume":"13","author":"Radu","year":"2023","journal-title":"Diagnostics (Basel)."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease","volume":"6","author":"Rau","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"B1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"a040501","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: concepts and scope","volume":"12","author":"Richmond","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat Dis. Int."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125662","article-title":"The polysaccharides from Auricularia auricula alleviate non-alcoholic fatty liver disease via modulating gut microbiota and bile acids metabolism","volume":"246","author":"Shu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41577-019-0144-5","article-title":"Mining the microbiota for microbial and metabolite-based immunotherapies","volume":"19","author":"Skelly","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41579-021-00559-y","article-title":"Prevotella diversity, niches and interactions with the human host","volume":"19","author":"Tett","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1115014","article-title":"Roles of gut microbiome in epilepsy risk: A Mendelian randomization study","volume":"14","author":"Zeng","year":"2023","journal-title":"Front. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114033","article-title":"Regulating the gut microbiota and SCFAs in the faeces of T2DM rats should be one of antidiabetic mechanisms of mogrosides in the fruits of Siraitia grosvenorii","volume":"274","author":"Zhang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.631061","article-title":"Assessment of causal direction between gut microbiota and inflammatory bowel disease: A mendelian randomization analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Genet."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1159148","article-title":"Investigating causal associations among gut microbiota, metabolites, and liver diseases: a Mendelian randomization study","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1294826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T11:52:43Z","timestamp":1701517963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1294826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":44,"alternative-id":["10.3389\/fcimb.2023.1294826"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1294826","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"article-number":"1294826"}}